These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26510857)

  • 1. Right-Sizing Adjuvant and Neoadjuvant Clinical Trials in Breast Cancer.
    Berry DA
    Clin Cancer Res; 2016 Jan; 22(1):3-5. PubMed ID: 26510857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Mauri D; Pavlidis N; Ioannidis JP
    J Natl Cancer Inst; 2005 Feb; 97(3):188-94. PubMed ID: 15687361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for operable breast cancer.
    Green M; Hortobagyi GN
    Oncology (Williston Park); 2002 Jul; 16(7):871-84, 889; discussion 889-90, 892-4, 897-8. PubMed ID: 12164555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.
    Killelea BK; Yang VQ; Mougalian S; Horowitz NR; Pusztai L; Chagpar AB; Lannin DR
    J Am Coll Surg; 2015 Jun; 220(6):1063-9. PubMed ID: 25868410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer.
    Kennedy CR; Gao F; Margenthaler JA
    J Surg Res; 2010 Sep; 163(1):52-7. PubMed ID: 20599225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neoadjuvant chemotherapy in the management of primary breast cancer.
    Aigner J; Schneeweiss A; Sohn C; Marmé F
    Minerva Ginecol; 2011 Jun; 63(3):261-74. PubMed ID: 21654611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
    Wynendaele W; van Oosterom AT
    Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Popat S; Smith IE
    J Natl Cancer Inst; 2005 Jun; 97(11):858; author reply 858-9. PubMed ID: 15928308
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
    Gianni L; Eiermann W; Semiglazov V; Manikhas A; Lluch A; Tjulandin S; Zambetti M; Vazquez F; Byakhow M; Lichinitser M; Climent MA; Ciruelos E; Ojeda B; Mansutti M; Bozhok A; Baronio R; Feyereislova A; Barton C; Valagussa P; Baselga J
    Lancet; 2010 Jan; 375(9712):377-84. PubMed ID: 20113825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine therapy as adjuvant or neoadjuvant therapy for breast cancer: selecting the best agents, the timing and duration of treatment.
    Li JJ; Shao ZM
    Chin Clin Oncol; 2016 Jun; 5(3):40. PubMed ID: 27164856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis.
    Zhang N; Moran MS; Huo Q; Haffty BG; Yang Q
    Cancer Invest; 2011 Nov; 29(9):594-8. PubMed ID: 22011281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials.
    Solinas C; Ceppi M; Lambertini M; Scartozzi M; Buisseret L; Garaud S; Fumagalli D; de Azambuja E; Salgado R; Sotiriou C; Willard-Gallo K; Ignatiadis M
    Cancer Treat Rev; 2017 Jun; 57():8-15. PubMed ID: 28525810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials.
    Reinisch M; Huober J; von Minckwitz G; Blohmer JU; Denkert C; Hanusch C; Jackisch C; Kümmel S; Schneeweiss A; Rhiem K; Lederer B; Untch M; Nekljudova V V; Loibl S
    Breast; 2017 Apr; 32():73-78. PubMed ID: 28063331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of neoadjuvant chemotherapy on the overall treatment strategy in operable breast cancer].
    Zuo WS; Zheng MZ; Han C
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):952-957. PubMed ID: 29262515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future role of neoadjuvant therapy for breast cancer.
    Untch M; Konecny GE; Paepke S; von Minckwitz G
    Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating neoadjuvant therapy into survival benefits: one size does not fit all.
    De Mattos-Arruda L; Shen R; Reis-Filho JS; Cortés J
    Nat Rev Clin Oncol; 2016 Sep; 13(9):566-79. PubMed ID: 27000962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer.
    Al-Hilli Z; Boughey JC
    Chin Clin Oncol; 2016 Jun; 5(3):37. PubMed ID: 27164853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy in the treatment of breast cancer.
    Redden MH; Fuhrman GM
    Surg Clin North Am; 2013 Apr; 93(2):493-9. PubMed ID: 23464698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.